293 related articles for article (PubMed ID: 28472690)
1. Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats.
Xu Y; Asghar S; Yang L; Chen Z; Li H; Shi W; Li Y; Shi Q; Ping Q; Xiao Y
Int J Biol Macromol; 2017 Sep; 102():1083-1091. PubMed ID: 28472690
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma.
Xu Y; Asghar S; Yang L; Li H; Wang Z; Ping Q; Xiao Y
Carbohydr Polym; 2017 Feb; 157():419-428. PubMed ID: 27987946
[TBL] [Abstract][Full Text] [Related]
7. Understanding the cellular uptake and biodistribution of a dual-targeting carrier based on redox-sensitive hyaluronic acid-ss-curcumin micelles for treating brain glioma.
Tian C; Asghar S; Hu Z; Qiu Y; Zhang J; Shao F; Xiao Y
Int J Biol Macromol; 2019 Sep; 136():143-153. PubMed ID: 31199976
[TBL] [Abstract][Full Text] [Related]
8. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells.
Singh SP; Sharma M; Gupta PK
Int J Biol Macromol; 2015 Mar; 74():162-70. PubMed ID: 25511568
[TBL] [Abstract][Full Text] [Related]
10. Chitosan hydrochloride/hyaluronic acid nanoparticles coated by mPEG as long-circulating nanocarriers for systemic delivery of mitoxantrone.
Wang J; Asghar S; Yang L; Gao S; Chen Z; Huang L; Zong L; Ping Q; Xiao Y
Int J Biol Macromol; 2018 Jul; 113():345-353. PubMed ID: 29486258
[TBL] [Abstract][Full Text] [Related]
11. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
12. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
13.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
14. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
15. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
17. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
19. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
[TBL] [Abstract][Full Text] [Related]
20. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
